Abstract
Background: To evaluate the clinical efficacy and safety of unilateral spinal anaesthesia with 0.66% hyperbaric ropivacaine compared with 0.5% hyperbaric bupivacaine for arthroscopic knee surgery.
Patients and methods: Forty patients with American Society of Anesthesiology physical status grade I–II were randomly and double blindly allocated to one of two groups. Spinal anaesthesia was performed from the L3-4 or L4-5 interspace with the patient in the lateral decubitus position and with the operative side below. Group B (n = 20) received 7.5mg of 0.5% hyperbaric bupivacaine and group R (n = 20) received 10mg of 0.66% hyperbaric ropivacaine. Patients stayed in the lateral decubitus position for 10 minutes and were then turned to the supine position. The characteristics of spinal block, intraoperative quality of spinal anaesthesia, adverse effects and recovery times were recorded.
Results: The onset of sensory block and motor block were significantly earlier in group B compared with group R (p < 0.05). The duration of sensory block and motor block were significantly shorter for group R compared with group B (p < 0.05). Bilateral sensory block occurred in 85% of patients in group B and in 40% of patients in group R (p < 0.05). Bilateral motor block occurred in 70% of patients in group B and in 25% of patients in group R (p < 0.05).
Conclusion: For outpatient knee arthroscopy, 10mg of 0.66% hyperbaric ropivacaine is preferred to 7.5mg of 0.5% hyperbaric bupivacaine because it provides a more selective unilateral block and a faster recovery.
Similar content being viewed by others
References
White PF. Outpatient anesthesia. In: Miller RD, editor. Anesthesia. 3rd ed. New York: Churchill-Livingstone, 1990: 2025–59
Pollock JE, Neal JM, Stephenson CA, et al. Prospective study of incidence of transient radicular irritation in patients undergoing spinal anesthesia. Anesthesiology 1996; 84: 1361–7
Liu SS, Ware PD, Allen HW, et al. Dose response characteristics of spinal bupivacaine in volunteers. Clinical applications for ambulatory anesthesia. Anesthesiology 1996; 85: 729–36
Pittoni G, Teffeletto F, Calcarella G, et al. Spinal anesthesia in outpatient knee surgery: 22-gauge versus 25-gauge Sprotte needle. Anesth Analg 1995; 81: 73–9
Ben David B, Levin H, Solomon E, et al. Spinal bupivacaine in ambulatory surgery: the effect of saline dilution. Anesth Analg 1996; 83: 716–20
Akerman B, Helberg B, Trossvik C. Primary evaluation of the local anaesthetic properties of the amino amide agent ropivacaine (LEA 103). Acta Anaesthesiol Scand 1988; 32: 571–8
McClure JH. Ropivacaine. Br J Anaesth 1996; 76: 300–7
Fanelli G, Casati A, Beccaria P, et al. Bilateral versus unilateral selective subarachnoid anaesthesia: cardiovascular haemostasis [abstract]. Br J Anaesth 1996; 76Suppl. 2: 242
Kim KC, Moneta MD. Unilateral spinal anaesthesia can be obtained with low dose bupivacaine [abstract]. Anaesthesiology 1992; 77: A803
Levin A, Datta S, Camann WR. Intrathecal ropivacaine for labour analgesia: a comparison with bupivacaine. Anesth Analg 1998; 87: 624–7
Van Kleef JW, Veering BT, Burm AGL. Spinal anesthesia with ropivacaine: a double-blind study of efficacy and safety of 0.5% and 0.75% solutions in patients undergoing minor lower limb surgery. Anesth Analg 1994; 90: 971–7
Casati A, Moizo E, Marchetti C, et al. A prospective, randomized, double-blind comparison of unilateral spinal anesthesia with hyperbaric bupivacaine, ropivacaine, or levobupivacaine for inguinal herniorrhaphy. Anesth Analg 2004; 99: 1387–92
McNamee DA, Parks L, McClelland AM, et al. Intrathecal ropivacaine for total hip arthroplasty: double-blind comparative study with isobaric 7.5mg/ml and 10mg/ml solutions. Br J Anaesth 2001; 87(5): 743–7
Cappelleri G, Aldegheri G, Danelli G, et al. Spinal anesthesia with hyperbaric levobupivacaine and ropivacaine for out- patient knee arthroscopy: a prospective, randomized, double blind study. Anesth Analg 2005; 101: 77–82
Hampl K, Schneider M, Pargger H, et al. A similar incidence of transient neurologic symptoms after spinal anesthesia with 2% and 5% lidocaine. Anesth Analg 1996; 83: 1051–4
McDonald SB, Liu SS, Kopacz DJ, et al. Hyperbaric spinal ropivacaine: a comparison to bupivacaine in volunteers. Anesthesiolgy 1999; 90: 971–7
Gautrier PE, De Kock M, Van Steenberge A, et al. Intrathecal ropivacaine for ambulatory surgery: a comparison between intrathecal bupivacaine and ropivacaine for knee arthroscopy. Anesthesiology 1999; 91: 1239–45
Browner WS, Black D, Newman B, et al. Estimating sample size and power. In: Hulley SB, Cummings SR, editors. Designing clinical research: an epidemiologic approach. B ltimore: Williams & Wilkins, 1988: 139–50
Hampl KL, Schneider MC, Ummenhoffer W, et al. Transient neurologic symptoms after spinal anesthesia. Anesth Analg 1995; 81: 1148–53
Schneider M, Etlin T, Kaufmann M, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg 1993; 76: 1154–7
Feldman HS, Covino BG. Comparative motor blocking effects of bupivacaine and ropivacaine, a new amino amide local anesthetic, in the rat and dog. Anesth Analg 1988; 67: 1047–52
Kristensen JD, Karlsten R, Gordh T. Spinal cord blood flow after intrathecal injection of ropivacaine and bupivacaine with or without epinephrine in rats. Acta Anaesthesiol Scand 1998; 42: 685–90
Kristensen JD, Karlsten R, Gordh T. Spinal cord blood flow after intrathecal injection of ropivacaine. Anesth Analg 1996; 82: 636–40
Casati A, Fanelli G, Berti M, et al. Cardiac performance during unilateral lumbar spinal block after crystalloid preload. Can J Anaesth 1997; 44: 623–8
Acknowledgements
This study was supported by Akdeniz University Scientific Research Project Unit, Antalya, Turkey. The authors have no potential conflicts of interest that are directly relevant to the contents of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bigat, Z., Boztug, N., Karsli, B. et al. Comparison of Hyperbaric Ropivacaine and Hyperbaric Bupivacaine in Unilateral Spinal Anaesthesia. Clin. Drug Investig. 26, 35–41 (2006). https://doi.org/10.2165/00044011-200626010-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00044011-200626010-00005